These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28770589)

  • 1. Implications of differentiated care for successful ART scale-up in a concentrated HIV epidemic in Yangon, Myanmar.
    Mesic A; Fontaine J; Aye T; Greig J; Thwe TT; Moretó-Planas L; Kliesckova J; Khin K; Zarkua N; Gonzalez L; Guillergan EL; O'Brien DP
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21644. PubMed ID: 28770589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
    Grimsrud A; Kaplan R; Bekker LG; Myer L
    Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar.
    Kyaw NTT; Kumar AMV; Oo MM; Oo HN; Kyaw KWY; Thiha S; Aung TK; Win T; Mon YY; Harries AD
    Glob Health Action; 2017; 10(1):1290916. PubMed ID: 28594295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis.
    Mesic A; Spina A; Mar HT; Thit P; Decroo T; Lenglet A; Thandar MP; Thwe TT; Kyaw AA; Homan T; Sangma M; Kremer R; Grieg J; Piriou E; Ritmeijer K; Van Olmen J; Lynen L; Oo HN
    AIDS Res Ther; 2021 Apr; 18(1):16. PubMed ID: 33882962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016.
    Aung ZZ; Oo MM; Tripathy JP; Kyaw NTT; Hone S; Oo HN; Majumdar SS
    PLoS One; 2018; 13(9):e0204550. PubMed ID: 30252904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV care in Yangon, Myanmar; successes, challenges and implications for policy.
    Aung NM; Hanson J; Kyi TT; Htet ZW; Cooper DA; Boyd MA; Kyi MM; Saw HA
    AIDS Res Ther; 2017 Mar; 14(1):10. PubMed ID: 28257647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study.
    Thinn KK; Thekkur P; Kyaw NTT; Aye NS; Zaw TM; Soan P; Hone S; Oo HN
    BMJ Open; 2019 Dec; 9(12):e032678. PubMed ID: 31796489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Success With Retention in Care Among People Living With HIV at Decentralized ART Satellite Sites in Yangon, Myanmar, 2015-2016.
    Htet KM; Soe KT; Oo MM; Hone S; Majumdar SS; Oo HN
    Front Public Health; 2019; 7():124. PubMed ID: 31179261
    [No Abstract]   [Full Text] [Related]  

  • 12. High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015.
    Kyaw NT; Harries AD; Kumar AM; Oo MM; Kyaw KW; Win T; Aung TK; Min AC; Oo HN
    PLoS One; 2017; 12(2):e0171780. PubMed ID: 28182786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Standardized Pediatric Expedited Encounters for ART Drugs Initiative (SPEEDI): description and evaluation of an innovative pediatric, adolescent, and young adult antiretroviral service delivery model in Tanzania.
    Bacha JM; Aririguzo LC; Mng'ong'o V; Malingoti B; Wanless RS; Ngo K; Campbell LR; Schutze GE
    BMC Infect Dis; 2018 Sep; 18(1):448. PubMed ID: 30176821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-supported models of care for people on HIV treatment in sub-Saharan Africa.
    Bemelmans M; Baert S; Goemaere E; Wilkinson L; Vandendyck M; van Cutsem G; Silva C; Perry S; Szumilin E; Gerstenhaber R; Kalenga L; Biot M; Ford N
    Trop Med Int Health; 2014 Aug; 19(8):968-77. PubMed ID: 24889337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care.
    Bemelmans M; van den Akker T; Ford N; Philips M; Zachariah R; Harries A; Schouten E; Hermann K; Mwagomba B; Massaquoi M
    Trop Med Int Health; 2010 Dec; 15(12):1413-20. PubMed ID: 20958897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders.
    Ehrenkranz PD; Calleja JM; El-Sadr W; Fakoya AO; Ford N; Grimsrud A; Harris KL; Jed SL; Low-Beer D; Patel SV; Rabkin M; Reidy WJ; Reinisch A; Siberry GK; Tally LA; Zulu I; Zaidi I
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of community-based differentiated models of multi-month dispensing of antiretroviral medication among stable HIV-infected patients in Lesotho: a cluster randomised non-inferiority trial protocol.
    Faturiyele IO; Appolinare T; Ngorima-Mabhena N; Fatti G; Tshabalala I; Tukei VJ; Pisa PT
    BMC Public Health; 2018 Aug; 18(1):1069. PubMed ID: 30157896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya.
    Hagey JM; Li X; Barr-Walker J; Penner J; Kadima J; Oyaro P; Cohen CR
    AIDS Care; 2018 Dec; 30(12):1477-1487. PubMed ID: 30037312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.
    Bermúdez-Aza EH; Shetty S; Ousley J; Kyaw NTT; Soe TT; Soe K; Mon PE; Tun KT; Ciglenecki I; Cristofani S; Fernandez M
    PLoS One; 2018; 13(2):e0191695. PubMed ID: 29420652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar.
    Murray J; Whitehouse K; Ousley J; Bermudez E; Soe TT; Hilbig A; Soe KP; Mon PE; Tun KT; Ei WLSS; Cyr J; Deglise C; Ciglenecki I
    BMC Infect Dis; 2020 Mar; 20(1):241. PubMed ID: 32197588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.